Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

BACKGROUND: MB66 film is a multipurpose prevention technology (MPT) product with monoclonal antibodies (mAbs) against HIV-1 (VRC01-N) and HSV-1 and 2 (HSV8-N). The mAbs were produced by transient expression in Nicotiana benthamiana (N). We conducted a Phase I clinical trial to assess the safety, pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Politch, Joseph A., Cu-Uvin, Susan, Moench, Thomas R., Tashima, Karen T., Marathe, Jai G., Guthrie, Kate M., Cabral, Howard, Nyhuis, Tara, Brennan, Miles, Zeitlin, Larry, Spiegel, Hans M. L., Mayer, Kenneth H., Whaley, Kevin J., Anderson, Deborah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857576/
https://www.ncbi.nlm.nih.gov/pubmed/33534791
http://dx.doi.org/10.1371/journal.pmed.1003495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857576/
https://www.ncbi.nlm.nih.gov/pubmed/33534791
http://dx.doi.org/10.1371/journal.pmed.1003495

Ejemplares similares